8-Ethyl-6-(4-methoxy-benzyl)-5,7-dioxo-5,6,7,8-tetrahydro-[1,3,4]thiadiazolo[3,2-a]pyrimidin-4-ylium

ID: ALA157698

Chembl Id: CHEMBL157698

PubChem CID: 44373266

Max Phase: Preclinical

Molecular Formula: C15H16N3O3S+

Molecular Weight: 318.38

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN1C(=O)C(Cc2ccc(OC)cc2)C(=O)[n+]2ncsc21

Standard InChI:  InChI=1S/C15H16N3O3S/c1-3-17-13(19)12(14(20)18-15(17)22-9-16-18)8-10-4-6-11(21-2)7-5-10/h4-7,9,12H,3,8H2,1-2H3/q+1

Standard InChI Key:  GBPCYESNXOCIMJ-UHFFFAOYSA-N

Associated Targets(non-human)

PDE1B Heart phosphodiesterase (70 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 318.38Molecular Weight (Monoisotopic): 318.0907AlogP: 1.30#Rotatable Bonds: 4
Polar Surface Area: 63.38Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: 8.69CX Basic pKa: CX LogP: -0.71CX LogD: -0.73
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.63Np Likeness Score: -0.32

References

1. Glennon RA, Rogers ME, Smith JD, El-Said MK, Egle JL..  (1981)  Mesoionic xanthine analogues: phosphodiesterase inhibitory and hypotensive activity.,  24  (6): [PMID:6265635] [10.1021/jm00138a002]

Source